Health and Me

Tanya Dutt

Breakthrough Vaccine Could Stop Pancreatic Cancer From Returning- Here Are 6 Signs of The Deadly Disease

Pancreatic <span><a href="https://www.healthandme.com/health/cancer">cancer</a></span> has long been one of the toughest challenges in oncology. With a five-year survival rate hovering around 13% and recurrence rates approaching 80% after treatment, the odds have historically been stacked against patients. Now, a new vaccine targeting a common cancer mutation may change that outlook and potentially save lives.

The experimental treatment, known as ELI-002 2P, has shown early promise in preventing aggressive pancreatic cancers from returning, according to findings published in Nature Medicine.

Part of the problem lies in timing. Pancreatic cancer symptoms are notoriously vague, often mimicking less serious conditions like gallstones or irritable bowel syndrome. This means many patients are diagnosed too late for surgery — the only potentially curative treatment.

Even for those lucky enough to undergo surgery and chemotherapy, microscopic cancer cells can remain in the body, lying in wait to trigger recurrence. These “invisible” cells can’t be detected on scans, but they can be identified through blood tests that pick up tumor DNA.

The ELI-002 2P vaccine is designed to target mutations in the KRAS gene, which is present in up to 90% of pancreatic cancers and about 40% of colon cancers. Historically, KRAS mutations were considered “undruggable” because the mutated proteins resemble normal ones so closely that the immune system ignores them.

The new vaccine sidesteps this problem by training the immune system to recognize these subtle differences. Using small chains of amino acids called peptides, the vaccine teaches T-cells the immune system’s attack force to find and destroy KRAS-mutated cells.

<h2>How the <span rel="noindex">Pancreatic Cancer Vaccine</span> Works?</h2>

Unlike personalized cancer vaccines that require sequencing each patient’s tumor, ELI-002 2P is “off-the-shelf.” This means it can be manufactured in bulk, speeding up access and lowering costs.

The vaccine also includes a special “tail” that helps the peptides stay longer in lymph nodes — where immune cells are activated — increasing the chance of a strong immune response.

The Phase 1 study enrolled 25 patients: 20 with pancreatic cancer and 5 with colon cancer. All had undergone surgery and chemotherapy but still had cancer DNA in their blood. Patients received up to six priming doses of the vaccine over several months, with 13 participants also receiving booster shots. The results were striking:

<ul><li>85% mounted an immune response to the KRAS mutations.</li><li>Two-thirds had a strong enough response to clear lingering cancer cells.</li><li>Nearly 70% developed immunity to other tumor targets not included in the vaccine.</li></ul>

In pancreatic cancer patients, the average survival was 29 months, with more than 15 months free from recurrence.

A handful of “super-responders” patients whose immune systems reacted exceptionally well enjoyed the best survival outcomes. Researchers noted that the strongest immune responses correlated with the longest recurrence-free periods, suggesting the vaccine directly contributed to these results.

Dr. Zev Wainberg, co-director of UCLA’s gastrointestinal oncology program, emphasized the urgency:

“If you were to ask me what disease most needs something to prevent recurrences, I’d say this one.”

<h2>Why This Could Be a Turning Point for Cancer Vaccines?</h2>

Cancer vaccines have a checkered history. The challenge lies in finding targets unique enough to cancer cells without harming healthy tissue. Advances in mRNA technology, faster genetic sequencing, and novel peptide designs are beginning to crack that code.

This KRAS-targeted vaccine offers a proof-of-concept that such approaches can work even against aggressive, mutation-driven cancers.

The promising early results have already led to a Phase 2 trial, comparing the vaccine against standard post-surgery care. If larger studies confirm the findings, ELI-002 2P could become a powerful addition to the pancreatic cancer treatment arsenal — and potentially extend to other KRAS-driven cancers.

Stephanie Dougan, an associate professor at Dana-Farber Cancer Institute, called the work “really exciting,” noting, “The fact that the long-term survival really correlated with T-cell response suggests that the vaccine caused this.”

<h2>Silent Warning Signs of Pancreatic Cancer</h2>

While this breakthrough offers hope, prevention and early detection remain vital. Experts warn that pancreatic cancer often masquerades as common ailments, delaying diagnosis. Here are some early symptoms that should never be ignored:

<ul><li>Abdominal or back pain that worsens over time or eases when leaning forward.</li><li>Unexplained weight loss without changes in diet or exercise.</li><li>Jaundice, including yellowing of the eyes and skin, sometimes with intense itching.</li><li>Changes to urine or stool, such as dark urine or pale, greasy stools.</li><li>New-onset diabetes without obvious risk factors.</li><li>Persistent fatigue unrelated to poor sleep or lifestyle.</li></ul>

These symptoms often appear in combination and warrant immediate medical attention — particularly for those with a family history of pancreatic cancer.

Pancreatic cancer has long been a grim diagnosis, but research like this signals a shift in momentum. An “off-the-shelf” vaccine that primes the immune system to attack one of cancer’s most notorious mutations could fundamentally change how doctors manage post-surgical treatment.

While the journey from early trial to approved therapy is long, the potential impact is hard to overstate. For patients facing one of the toughest cancers known to medicine, ELI-002 2P could one day mean the difference between a brief remission and a lasting cure.

Health Conditions A-Z

health

cancer

pancreatic cancer vaccine

cancer recurrence prevention

cancer immunotherapy

pancreatic cancer survival

new cancer treatment

cancer research breakthrough

Experts Warn Against The Unique Symptoms Of 'Stratus' Covid Strain That Has Infected A Large UK Population; Can It Evade Antibodies?

World Organ Donation Day 2025: Theme, History, And Importance

Monica Seles Says She Was Relieved With The Myasthenia Gravis Diagnosis, But It Has Changed Her Life

Health News

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

Superfoods That Support Your Gut Health

Immune-Boosting Foods To Have During Rainy Season

Potato Based Dishes You For Week-Long Meal Prep

Weight Loss Dishes With Fruits You Should Try

Stress Vs. Anxiety: Difference Explained In 60 seconds

Can You Get Heatstroke In Monsoon?

You’re Not Lazy! Women Do Need More Sleep Than Men

How To Ditch Daytime Sleepiness In Office?

Common Mistakes People Make While Eating Flaxseeds

Toddlers In India Are Missing Development Milestones: Study

Yoga Poses You Should Do For Back Pain

Healthy Brunch Ideas For A Lazy Weekend Meal

Balancing Exercises You Should Do For Stability

How Much Can Food Affect Menstruation?

What Should Fitness Look Like For A 13-18 Year Old

Food For Diabetes: What Should A Diabetic Diet Contain

You Don’t Always Need Weights For Strength Training

Feel Sleepy After Lunches - Light And Healthy Office Lunches

Positive Thinking Practice – How Does It Help You?

MIND Diet – Is This A Healthy Diet Or Another Trend?

Yoga Prop Essentials To Improve Your Exercise Session

Should Potatoes Be The Part Of A Healthy Diet?

Best And Worst Foods To Lower Blood Pressure

Low-Impact Cardio Workouts You Should Try

10 Healthy Pasta Salad Dressing For Weight Loss

Breathing Exercise You Should Do To Relieve Stress

Headache vs. Migraine: Difference Explained In 60 Seconds

How Many Times Do You Need To Wash Your Face?

Hypothyroidism Diet – What To Eat And What You Should Avoid

Stretches To Relieve Leg Pain And Numbness After Sitting For Too Long

No-Cook Healthy Meals For Lazy Days At Home

Easy Breakfast Options To Try During Calorie Deficit

How To Stop Muscle Cramps Immediately

Pancreatic cancer has long been one of the toughest challenges in oncology. With a five-year survival rate hovering around 13% and recurrence rates approaching 80% after treatment, the odds have historically been stacked against patients. Now, a new vaccine targeting a common cancer mutation may change that outlook and potentially save lives.The experimental treatment, known as ELI-002 2P, has shown early promise in preventing aggressive pancreatic cancers from returning, according to findings published in Nature Medicine.Part of the problem lies in timing. Pancreatic cancer symptoms are notoriously vague, often mimicking less serious conditions like gallstones or irritable bowel syndrome. This means many patients are diagnosed too late for surgery — the only potentially curative treatment.Even for those lucky enough to undergo surgery and chemotherapy, microscopic cancer cells can remain in the body, lying in wait to trigger recurrence. These “invisible” cells can’t be detected on scans, but they can be identified through blood tests that pick up tumor DNA.The ELI-002 2P vaccine is designed to target mutations in the KRAS gene, which is present in up to 90% of pancreatic cancers and about 40% of colon cancers. Historically, KRAS mutations were considered “undruggable” because the mutated proteins resemble normal ones so closely that the immune system ignores them.The new vaccine sidesteps this problem by training the immune system to recognize these subtle differences. Using small chains of amino acids called peptides, the vaccine teaches T-cells the immune system’s attack force to find and destroy KRAS-mutated cells.How the Pancreatic Cancer Vaccine Works?Unlike personalized cancer vaccines that require sequencing each patient’s tumor, ELI-002 2P is “off-the-shelf.” This means it can be manufactured in bulk, speeding up access and lowering costs.The vaccine also includes a special “tail” that helps the peptides stay longer in lymph nodes — where immune cells are activated — increasing the chance of a strong immune response.The Phase 1 study enrolled 25 patients: 20 with pancreatic cancer and 5 with colon cancer. All had undergone surgery and chemotherapy but still had cancer DNA in their blood. Patients received up to six priming doses of the vaccine over several months, with 13 participants also receiving booster shots. The results were striking:85% mounted an immune response to the KRAS mutations.Two-thirds had a strong enough response to clear lingering cancer cells.Nearly 70% developed immunity to other tumor targets not included in the vaccine.In pancreatic cancer patients, the average survival was 29 months, with more than 15 months free from recurrence.A handful of “super-responders” patients whose immune systems reacted exceptionally well enjoyed the best survival outcomes. Researchers noted that the strongest immune responses correlated with the longest recurrence-free periods, suggesting the vaccine directly contributed to these results.Dr. Zev Wainberg, co-director of UCLA’s gastrointestinal oncology program, emphasized the urgency:“If you were to ask me what disease most needs something to prevent recurrences, I’d say this one.”Why This Could Be a Turning Point for Cancer Vaccines?Cancer vaccines have a checkered history. The challenge lies in finding targets unique enough to cancer cells without harming healthy tissue. Advances in mRNA technology, faster genetic sequencing, and novel peptide designs are beginning to crack that code.This KRAS-targeted vaccine offers a proof-of-concept that such approaches can work even against aggressive, mutation-driven cancers.The promising early results have already led to a Phase 2 trial, comparing the vaccine against standard post-surgery care. If larger studies confirm the findings, ELI-002 2P could become a powerful addition to the pancreatic cancer treatment arsenal — and potentially extend to other KRAS-driven cancers.Stephanie Dougan, an associate professor at Dana-Farber Cancer Institute, called the work “really exciting,” noting, “The fact that the long-term survival really correlated with T-cell response suggests that the vaccine caused this.”Silent Warning Signs of Pancreatic CancerWhile this breakthrough offers hope, prevention and early detection remain vital. Experts warn that pancreatic cancer often masquerades as common ailments, delaying diagnosis. Here are some early symptoms that should never be ignored:Abdominal or back pain that worsens over time or eases when leaning forward.Unexplained weight loss without changes in diet or exercise.Jaundice, including yellowing of the eyes and skin, sometimes with intense itching.Changes to urine or stool, such as dark urine or pale, greasy stools.New-onset diabetes without obvious risk factors.Persistent fatigue unrelated to poor sleep or lifestyle.These symptoms often appear in combination and warrant immediate medical attention — particularly for those with a family history of pancreatic cancer.Pancreatic cancer has long been a grim diagnosis, but research like this signals a shift in momentum. An “off-the-shelf” vaccine that primes the immune system to attack one of cancer’s most notorious mutations could fundamentally change how doctors manage post-surgical treatment.While the journey from early trial to approved therapy is long, the potential impact is hard to overstate. For patients facing one of the toughest cancers known to medicine, ELI-002 2P could one day mean the difference between a brief remission and a lasting cure.

breakthrough vaccine could stop pancreatic cancer from returning- here are 6 signs of the deadly disease

Ishita Roy

If You Are Scared Of Needles, Scientists May Have A 'Painless' Dental Solution For Your Next Vaccine

if you are scared of needles, scientists may have a 'painless' dental solution for your next vaccine

Over 90% Of ER Patients Aren’t Fully Vaccinated—Is The Vaccination Gap Putting Everyone At Risk?

over 90% of er patients aren’t fully vaccinated—is the vaccination gap putting everyone at risk?

Health & Wellness

Health Warning Issued By UKHSA In England As Fourth Heatwave Nears

health warning issued by ukhsa in england as fourth heatwave nears

Colon Cancer Screenings Help Catch The Deadly Disease Earlier - Is Pencil Thin Stool A Sign Or Myth?

colon cancer screenings help catch the deadly disease earlier - is pencil thin stool a sign or myth?

The UKHSA has noted that a new strain of <span>COVID-19</span> virus, called Stratus, with two variants, XFG and XFG.3, has accounted for a high proportion cases in England, reports the <em>Independent</em>. Among these two variants, XFG.3 has accounted for 30% of cases in the country.

However, experts have suggested to not panic on the arrival of this new strain. Dr Alex Allen, consultant epidemiologist of UKHSA said, "It is normal for viruses to mutate and change over time," as reported by the <em>Independent</em>. However, the UKHSA has also confirmed that it continues to monitor all strains of <span>COVID</span> in the UK. For now, experts are not concerned over the spread.

As per the World Health Organization (WHO), XFG is a "variant under monitoring" and that any health risk posed by this variant remain low at the global level.

As of now, globally, XFG has the highest relative growth when compared to the other variants that are currently active and circulating, including "Nimbus" NB.1.8.1.

The WHO also confirmed that current data does not indicate that this variant leads to more severe illness or deaths than the other currently active variants in circulation. 

<h4>Unique Symptoms Of <span rel="noindex">Stratus COVID Strain</span></h4>

While the strain is said to be not a cause of concern, the symptoms may be unique from what we traditionally know COVID symptoms to be. 

The WHO however, time and again has said that there is no increase in severity. It said, "While there are reported increases in cases and hospitalisations in some of the [South-east Asia Region] countries, which has the highest proportion of XFG, there are no reports to suggest that the associated disease severity is higher as compared to other circulating variants."

Dr Allen also seconded the opinion and said, "Based on the available information so far, there is no evidence to suggest that the XFG and XFG.3 variants cause more severe disease than previous variants, or that the vaccines in current use will be less effective against them.”

<strong>The unique symptoms of Stratus COVID strain includes:</strong>

<ul><li>Sore throat or hoarseness, as experts have also claimed that Stratus can give patients a "hoarse voice".</li><li>Headaches that can last several days</li><li>Nasal congestion and mild fever</li><li>Fatigue that lingers beyond acute phase</li></ul>

Other than these unique symptoms, the common COVID symptoms like change in smell or taste, shortness of breath and chest discomfort remain, however, it may be uncommon in vaccinated individuals. 

<h4>Are There Any Risks Around The New Stratus Strain?</h4>

XFG is growing rapidly compared to co-circulating variants globally. However, XFG exhibits only marginal additional immune evasion over [other varient] LP.8.1. While there are reported increases in cases and hospitalizations in some of the [South-east Asia Region] countries, which has the highest proportion of XFG, there are no reports to suggest that the associated disease severity is higher as compared to other circulating variants. The available evidence on XFG does not suggest additional public health risks relative to the other currently circulating Omicron descendant lineages," said WHO. 

<h4>Do We Need New Vaccines For The New Strain?</h4>

The WHO said that as per the current available data, the currently approved COVID-19 vaccines are expected to remain effective against symptomatic and severe diseases, including caused by the new strain. 

However, Dr Kaywaan Khan, Harley Street GP and founder of Hannah London Clinic told <em>Cosmopolitan </em><em>UK </em>that due to certain mutations in the spike protein in Stratus strain, it could evade antibodies "developed from prior infections or vaccinations".

While WHO noted that the risk of vaccine evasion is low, it also noted that more studies must be added to assess the risk of antibody escape. 

COVID-19

stratus covid 19

health news

Stratus COVID strain

COVID

covid 19

COVID 19 new strain

Stratus strain COVID 19

XFG strain Stratus

New COVID Strain

The UKHSA has noted that a new strain of COVID-19 virus, called Stratus, with two variants, XFG and XFG.3, has accounted for a high proportion cases in England, reports the Independent. Among these two variants, XFG.3 has accounted for 30% of cases in the country.However, experts have suggested to not panic on the arrival of this new strain. Dr Alex Allen, consultant epidemiologist of UKHSA said, "It is normal for viruses to mutate and change over time," as reported by the Independent. However, the UKHSA has also confirmed that it continues to monitor all strains of COVID in the UK. For now, experts are not concerned over the spread.What Is Stratus XFG and XFG.3?As per the World Health Organization (WHO), XFG is a "variant under monitoring" and that any health risk posed by this variant remain low at the global level.As of now, globally, XFG has the highest relative growth when compared to the other variants that are currently active and circulating, including "Nimbus" NB.1.8.1.The WHO also confirmed that current data does not indicate that this variant leads to more severe illness or deaths than the other currently active variants in circulation. Unique Symptoms Of Stratus COVID StrainWhile the strain is said to be not a cause of concern, the symptoms may be unique from what we traditionally know COVID symptoms to be. The WHO however, time and again has said that there is no increase in severity. It said, "While there are reported increases in cases and hospitalisations in some of the [South-east Asia Region] countries, which has the highest proportion of XFG, there are no reports to suggest that the associated disease severity is higher as compared to other circulating variants."Dr Allen also seconded the opinion and said, "Based on the available information so far, there is no evidence to suggest that the XFG and XFG.3 variants cause more severe disease than previous variants, or that the vaccines in current use will be less effective against them.”The unique symptoms of Stratus COVID strain includes:Sore throat or hoarseness, as experts have also claimed that Stratus can give patients a "hoarse voice".Headaches that can last several daysNasal congestion and mild feverFatigue that lingers beyond acute phaseOther than these unique symptoms, the common COVID symptoms like change in smell or taste, shortness of breath and chest discomfort remain, however, it may be uncommon in vaccinated individuals. Are There Any Risks Around The New Stratus Strain?XFG is growing rapidly compared to co-circulating variants globally. However, XFG exhibits only marginal additional immune evasion over [other varient] LP.8.1. While there are reported increases in cases and hospitalizations in some of the [South-east Asia Region] countries, which has the highest proportion of XFG, there are no reports to suggest that the associated disease severity is higher as compared to other circulating variants. The available evidence on XFG does not suggest additional public health risks relative to the other currently circulating Omicron descendant lineages," said WHO. Do We Need New Vaccines For The New Strain?The WHO said that as per the current available data, the currently approved COVID-19 vaccines are expected to remain effective against symptomatic and severe diseases, including caused by the new strain. However, Dr Kaywaan Khan, Harley Street GP and founder of Hannah London Clinic told Cosmopolitan UK that due to certain mutations in the spike protein in Stratus strain, it could evade antibodies "developed from prior infections or vaccinations".While WHO noted that the risk of vaccine evasion is low, it also noted that more studies must be added to assess the risk of antibody escape. 

experts warn against the unique symptoms of 'stratus' covid strain that has infected a large uk population; can it evade antibodies?

Could Your Air Conditioning System Be Increasing The Risk Of 'Sick Building Syndrome'

could your air conditioning system be increasing the risk of 'sick building syndrome'

Blocking Brain-Liver Signals Could Stop Cancer-Related Weight Loss, New Study Reveals

blocking brain-liver signals could stop cancer-related weight loss, new study reveals

Trump’s Cuts Threaten Contraception; Meanwhile Social Media Says Birth Control Is 'Dangerous'

trump’s cuts threaten contraception, meanwhile social media says birth control is 'dangerous'

A Woman Finally Gets Her 18.5 Kg Fibroid Uterus Removed After 6 Years, Doctor Say She Was Carrying The Weight Of 5 New Born Babies

a woman finally gets her 18.5 kg fibroid uterus removed after 6 years, doctor say she was carrying the weight of 5 new born babies

Every year, on August 13, <span>World Organ Donation Day</span> is observed, globally, to spread awareness about the importance of <span>organ donation</span> and to make people aware about the misconceptions that surround organ donation. 

<h4><span rel="noindex">World Organ Donation Day 2025</span> Theme And Significance</h4>

This year's theme for World <span>Organ Donation Day</span> is 'Answering the Call'. This theme highlights the important function played by the professionals in the organ donation community. What it means is to encourage more to strengthen their dedication to save as many lives as possible through organ donation and transplantation. 

The Pace Hospital notes that as of 2021, globally, 1,44,302 organ transplantations had occurred, of which, 26.44% were of deceased organ donation. India performed a total of 12,259 transplantation, contributing to 8% in global transplantations. In India, the most transplants that took place were for kidneys at 74.27%, liver at 23.33%, heart at 1.23%, lung at 1.08%, pancreas at 0.15%, and small intestine at 0.03%. 

The overall number of deceased donors transplantation in India was 4.5%. While the deceased donors transplantation in India was reported 759 for kidney, 279 for liver and 99 for heart, the Indian Ministry of Health's estimated that it needs 175,000 kidneys, 50,000 livers, hearts, and lungs and 2,500 pancreas to meet the demand. 

The Indian Ministry of Road and Transport and Highway's 2021 report notes that more than 1.5 lakh were reported as accident-related mortalities, however, only 552 deceased brain deaths organ transplantations took place in 2021. This is why it is more so important to raise awareness about organ donation to help those in requirement and reducing the number of patients on the waiting list. 

It was in 1954, when the first successful organ transplant was performed. It was a kidney transplant by Dr Joseph Murray and his team at Peter Bent Brigham Hospital in Boston, Massachusetts. 

The donor was Ronald Lee Herrick, who donated his organ to his twin brother Richard Herrick. Later in 1990, the doctor was honored with Nobel Prize in Physiology and Medicine for bringing advances in organ transplantation.

Th United Network for Organ Sharing (UNOS) highlights the timeline of the first donations and transplants performed of different organs. 

<ul><li><strong>1996</strong>: First simultaneous kidney and pancreas transplant performed.</li><li><strong>1967</strong>: First successful liver transplant performed.</li><li><strong>1968</strong>: The Southeast Organ Procurement Foundation implemented the first computer-based organ matching system, which was dubbed as UNOS. It successfully performed the first isolated pancreas transplant and heart transplant.</li><li><strong>1981</strong>: First successful heart-lung transplant performed. </li><li><strong>1983</strong>: First successful single-lung transplant performed. Cyclosporine, the first of a number of drugs that effectively treat organ rejection by suppressing the human immune system, introduced.</li><li><strong>1984</strong>: National Organ Transplant Act (NOTA) was passed. </li><li><strong>1986</strong>: First successful double-lung transplant performed. </li><li><strong>1987</strong>: First successful intestinal transplant performed. </li><li><strong>1988</strong>: First split-liver transplant performed.</li><li><strong>1989</strong>: First successful living donor liver transplant performed.</li><li><strong>1990</strong>: First successful living donor lung transplant performed.</li><li><strong>1992</strong>: UNOS helped found Donate Life America to build public support for organ donation.</li><li><strong>1998</strong>: First successful adult-to-adult living donor liver transplant performed.</li></ul>

<h4>How Organ Donation Can Change A Life?</h4>

In March 2024, a dedicated Delhi-based teacher, Meena Mehta was declared brain dead and her organs were donated to many, including her hands, shared her nephew Jawed Mehta. A 45-year-old Delhi-based painter had lost both his hands in a 2020 train accident, who received hand transplant. The hands were of Meena Mehta. After a 12-hour long surgery, the painter was able to paint again. Meena Mehta also donated her kidney, liver, and corneas, which has changed lives of three more people.

world organ donation day

world organ donation day 2025

organ donation day

organ donation

organ donation day 2025

theme organ donation day

organ donation day 2025 theme

Every year, on August 13, World Organ Donation Day is observed, globally, to spread awareness about the importance of organ donation and to make people aware about the misconceptions that surround organ donation. World Organ Donation Day 2025 Theme And SignificanceThis year's theme for World Organ Donation Day is 'Answering the Call'. This theme highlights the important function played by the professionals in the organ donation community. What it means is to encourage more to strengthen their dedication to save as many lives as possible through organ donation and transplantation. The Pace Hospital notes that as of 2021, globally, 1,44,302 organ transplantations had occurred, of which, 26.44% were of deceased organ donation. India performed a total of 12,259 transplantation, contributing to 8% in global transplantations. In India, the most transplants that took place were for kidneys at 74.27%, liver at 23.33%, heart at 1.23%, lung at 1.08%, pancreas at 0.15%, and small intestine at 0.03%. The overall number of deceased donors transplantation in India was 4.5%. While the deceased donors transplantation in India was reported 759 for kidney, 279 for liver and 99 for heart, the Indian Ministry of Health's estimated that it needs 175,000 kidneys, 50,000 livers, hearts, and lungs and 2,500 pancreas to meet the demand. The Indian Ministry of Road and Transport and Highway's 2021 report notes that more than 1.5 lakh were reported as accident-related mortalities, however, only 552 deceased brain deaths organ transplantations took place in 2021. This is why it is more so important to raise awareness about organ donation to help those in requirement and reducing the number of patients on the waiting list. History Of Organ DonationIt was in 1954, when the first successful organ transplant was performed. It was a kidney transplant by Dr Joseph Murray and his team at Peter Bent Brigham Hospital in Boston, Massachusetts. The donor was Ronald Lee Herrick, who donated his organ to his twin brother Richard Herrick. Later in 1990, the doctor was honored with Nobel Prize in Physiology and Medicine for bringing advances in organ transplantation.Th United Network for Organ Sharing (UNOS) highlights the timeline of the first donations and transplants performed of different organs. 1996: First simultaneous kidney and pancreas transplant performed.1967: First successful liver transplant performed.1968: The Southeast Organ Procurement Foundation implemented the first computer-based organ matching system, which was dubbed as UNOS. It successfully performed the first isolated pancreas transplant and heart transplant.1981: First successful heart-lung transplant performed. 1983: First successful single-lung transplant performed. Cyclosporine, the first of a number of drugs that effectively treat organ rejection by suppressing the human immune system, introduced.1984: National Organ Transplant Act (NOTA) was passed. 1986: First successful double-lung transplant performed. 1987: First successful intestinal transplant performed. 1988: First split-liver transplant performed.1989: First successful living donor liver transplant performed.1990: First successful living donor lung transplant performed.1992: UNOS helped found Donate Life America to build public support for organ donation.1998: First successful adult-to-adult living donor liver transplant performed.How Organ Donation Can Change A Life?In March 2024, a dedicated Delhi-based teacher, Meena Mehta was declared brain dead and her organs were donated to many, including her hands, shared her nephew Jawed Mehta. A 45-year-old Delhi-based painter had lost both his hands in a 2020 train accident, who received hand transplant. The hands were of Meena Mehta. After a 12-hour long surgery, the painter was able to paint again. Meena Mehta also donated her kidney, liver, and corneas, which has changed lives of three more people.

world organ donation day 2025: theme, history, and importance

Tennis Player Monica Seles Opens Up About Her Myasthenia Gravis Diagnosis

tennis player monica seles opens up about her myasthenia gravis diagnosis

Waking Up With Red Eyes? 7 Possible Causes Your Body Might Be Sending These Warnings

waking up with red eyes? 7 possible causes your body might be sending these warnings

Voice Recording Could Reveal Early Warning Signs Of Laryngeal Cancer - What Features Reveal The Disease

voice recording could reveal early warning signs of laryngeal cancer - what features reveal the disease

Man Killed Eating Broccoli Sandwich, 9 More Rushed To Hospital, All Linked To One Street Vendor In Italy

man killed eating broccoli sandwich, 9 more rushed to hospital, all linked to one street vendor in italy

Nine-time Grand Slam champion <span>Monica Seles</span> is using her popularity and platform to shed light on a rare chronic neuromuscular condition that has changed her life. <span>Myasthenia Gravis</span>. 

In an interview with Good Morning America on Tuesday, the former World No. 1 revealed for the first time that she was diagnosed three years ago with myasthenia gravis, or MG, an <span>autoimmune disease</span> that causes muscle weakness.

"It was 30 years ago that I came back to the [U.S.] Open ... It was like a reset, and this was one of the reasons I decided to go public with my myasthenia gravis," Seles said. "It’s been a huge reset not just in my professional life as a tennis player, but also in my personal life."

Seles, who last played professionally in 2003 and officially retired in 2008, said she hopes her story will help others who may be struggling with unexplained symptoms.

The 51-year-old said her training as a professional athlete helped her notice early changes in her body.

"I started experiencing these symptoms of extreme leg weakness, arm weakness, double vision. So I realized, ‘This is very unusual,’" she explained. "<strong><em>Once I was diagnosed, it was like a relief, but also it was a challenge.</em></strong>"

Travel, once routine during her tennis career, has become more complicated. "Even coming here today, in the old days, traveling would be a no-brainer. Now I had to get packing tips. I had to learn a new way to live with MG," she said.

Seles admitted she had never heard of myasthenia gravis before her diagnosis. "I had no clue what it was. I had a hard time pronouncing it," she said with a smile. 

She hopes that talking about her experience will encourage people to seek medical advice if they notice changes in their health.

"It’s been a very challenging time dealing with it," she added. "But knowing there’s hope out there and a great community has helped me tremendously."

Her message to others: "Advocate for yourself and know your symptoms."

<strong>Also Read: <a href="https://www.healthandme.com/health-news/tennis-player-monica-seles-opens-up-about-her-myasthenia-gravis-diagnosis-article-152452748" data-type="tilCustomLink">Tennis Player Monica Seles Opens Up About Her Myasthenia Gravis Diagnosis</a></strong>

According to the U.S. National Institute of Neurological Disorders and Stroke (NINDS), myasthenia gravis is a chronic neuromuscular disease that causes weakness in voluntary muscles, the muscles responsible for movements like walking, swallowing, breathing, and facial expressions.

MG occurs when the immune system mistakenly attacks healthy muscle receptors, disrupting the signals needed for muscle contraction. Johns Hopkins Medicine notes that the condition is not inherited or contagious and often develops later in life.

The disease can affect anyone, but it most commonly impacts women under 40 and men over 60. Symptoms may include:

<ul><li>Drooping eyelids (ptosis) and double vision (diplopia)</li><li>Muscle weakness that worsens with activity</li><li>Trouble swallowing or speaking clearly</li><li>Weakness in the arms, legs, neck, or face</li><li>Shortness of breath in severe cases</li></ul>

Symptoms can vary widely between individuals. In rare situations, a myasthenic crisis may occur, affecting breathing muscles and requiring emergency medical care.

Because the symptoms of MG can resemble other health conditions, diagnosis involves a combination of physical and neurological exams, blood tests, and nerve stimulation studies.

There is currently no cure, but treatments can help manage symptoms and improve quality of life. These may include medications that enhance communication between nerves and muscles, immunosuppressive drugs, and in some cases, surgery to remove the thymus gland.

Temporary forms of MG can occur in newborns if a mother has the disease, but these cases usually resolve within two to three months.

While managing myasthenia gravis has brought challenges, Seles continues to find joy in life and in the sport she loves. She still follows tennis closely and is excited about the current generation of players.

"I wish I had a crystal ball," she said. "I love Coco Gauff, the electricity she brought to the U.S. Open. As a tennis fan, we just want great matches and the excitement of the fans."

By sharing her personal journey, Seles hopes to break the silence around MG and help others feel less alone. "When I got diagnosed, I wished I had heard someone talk about it. Now, I hope my story can be that for someone else."

Monica Seles

myasthenia gravis

Monica seles myasthenia gravis

monica seles autoimmune disease

autoimmune disease

myasthenia gravis monica seles

myasthenia gravis autoimmune disease

monia seles news

us health news

Nine-time Grand Slam champion Monica Seles is using her popularity and platform to shed light on a rare chronic neuromuscular condition that has changed her life. Myasthenia Gravis. In an interview with Good Morning America on Tuesday, the former World No. 1 revealed for the first time that she was diagnosed three years ago with myasthenia gravis, or MG, an autoimmune disease that causes muscle weakness."It was 30 years ago that I came back to the [U.S.] Open ... It was like a reset, and this was one of the reasons I decided to go public with my myasthenia gravis," Seles said. "It’s been a huge reset not just in my professional life as a tennis player, but also in my personal life."Seles, who last played professionally in 2003 and officially retired in 2008, said she hopes her story will help others who may be struggling with unexplained symptoms.Recognizing the SignsThe 51-year-old said her training as a professional athlete helped her notice early changes in her body."I started experiencing these symptoms of extreme leg weakness, arm weakness, double vision. So I realized, ‘This is very unusual,’" she explained. "Once I was diagnosed, it was like a relief, but also it was a challenge."Travel, once routine during her tennis career, has become more complicated. "Even coming here today, in the old days, traveling would be a no-brainer. Now I had to get packing tips. I had to learn a new way to live with MG," she said.Speaking Out to Help OthersSeles admitted she had never heard of myasthenia gravis before her diagnosis. "I had no clue what it was. I had a hard time pronouncing it," she said with a smile. She hopes that talking about her experience will encourage people to seek medical advice if they notice changes in their health."It’s been a very challenging time dealing with it," she added. "But knowing there’s hope out there and a great community has helped me tremendously."Her message to others: "Advocate for yourself and know your symptoms."Also Read: Tennis Player Monica Seles Opens Up About Her Myasthenia Gravis DiagnosisWhat Is Myasthenia Gravis?According to the U.S. National Institute of Neurological Disorders and Stroke (NINDS), myasthenia gravis is a chronic neuromuscular disease that causes weakness in voluntary muscles, the muscles responsible for movements like walking, swallowing, breathing, and facial expressions.MG occurs when the immune system mistakenly attacks healthy muscle receptors, disrupting the signals needed for muscle contraction. Johns Hopkins Medicine notes that the condition is not inherited or contagious and often develops later in life.The disease can affect anyone, but it most commonly impacts women under 40 and men over 60. Symptoms may include:Drooping eyelids (ptosis) and double vision (diplopia)Muscle weakness that worsens with activityTrouble swallowing or speaking clearlyWeakness in the arms, legs, neck, or faceShortness of breath in severe casesSymptoms can vary widely between individuals. In rare situations, a myasthenic crisis may occur, affecting breathing muscles and requiring emergency medical care.Diagnosis and TreatmentBecause the symptoms of MG can resemble other health conditions, diagnosis involves a combination of physical and neurological exams, blood tests, and nerve stimulation studies.There is currently no cure, but treatments can help manage symptoms and improve quality of life. These may include medications that enhance communication between nerves and muscles, immunosuppressive drugs, and in some cases, surgery to remove the thymus gland.Temporary forms of MG can occur in newborns if a mother has the disease, but these cases usually resolve within two to three months.Looking AheadWhile managing myasthenia gravis has brought challenges, Seles continues to find joy in life and in the sport she loves. She still follows tennis closely and is excited about the current generation of players."I wish I had a crystal ball," she said. "I love Coco Gauff, the electricity she brought to the U.S. Open. As a tennis fan, we just want great matches and the excitement of the fans."By sharing her personal journey, Seles hopes to break the silence around MG and help others feel less alone. "When I got diagnosed, I wished I had heard someone talk about it. Now, I hope my story can be that for someone else."

monica seles says she was relieved with the myasthenia gravis diagnosis, but it has changed her life

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Breakthrough Vaccine Could Stop Pancreatic Cancer From Returning- Here Are 6 Signs of The Deadly Disease

Quick Stories

Experts Warn Against The Unique Symptoms Of 'Stratus' Covid Strain That Has Infected A Large UK Population; Can It Evade Antibodies?

World Organ Donation Day 2025: Theme, History, And Importance

Monica Seles Says She Was Relieved With The Myasthenia Gravis Diagnosis, But It Has Changed Her Life

Health Conditions A-Z

Experts Warn Against The Unique Symptoms Of 'Stratus' Covid Strain That Has Infected A Large UK Population; Can It Evade Antibodies?

World Organ Donation Day 2025: Theme, History, And Importance

Monica Seles Says She Was Relieved With The Myasthenia Gravis Diagnosis, But It Has Changed Her Life